Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells

BACKGROUND: The aim of this in vitro study was to measure the enhanced anticancer effects of Res (resveratrol) on PA (paclitaxel) in HepG2 human liver cancer cells. METHODS: The MTT (thiazolyl blue tetrazolium bromide, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), flow cytometry, qP...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qin, Yang, Manyi, Qu, Zhan, Zhou, Jixiang, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628430/
https://www.ncbi.nlm.nih.gov/pubmed/28978315
http://dx.doi.org/10.1186/s12906-017-1956-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628430/
https://www.ncbi.nlm.nih.gov/pubmed/28978315
http://dx.doi.org/10.1186/s12906-017-1956-0

Ejemplares similares